{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T15:10:48Z","timestamp":1721747448676},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T00:00:00Z","timestamp":1326240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The immunological hallmark of Omenn syndrome (OS) is the expansion and activation of an oligoclonal population of autoreactive T cells. These cells should be controlled rapidly by immunosuppressive agents, such as cyclosporin A (CsA), to avoid tissue infiltration and to improve the general outcome of the patients. Here we studied the clinical and the immune response to CsA in two Omenn patients and also examined the gene expression profile associated with good clinical response to such therapy. T cell receptor diversity was studied in cells obtained from OS patients during CsA therapy. Characterization of gene expression in these cells was carried out by using the TaqMan low-density array. One patient showed complete resolution of his symptoms after CsA therapy. The other patient showed selective response of his oligoclonal T cell population and combination therapy was required to control his symptoms. Transcriptional profile associated with good clinical response to CsA therapy revealed significant changes in 26\u00b76% of the tested genes when compared with the transcriptional profile of the cells before treatment. Different clinical response to CsA in two OS patients is correlated with their immunological response. Varying clonal expansions in OS patients can cause autoimmune features and can respond differently to immunosuppressive therapy; therefore, additional treatment is sometimes indicated. CsA for OS patients causes regulation of genes that are involved closely with self-tolerance and autoimmunity.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04508.x","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T11:51:05Z","timestamp":1319802665000},"page":"338-345","source":"Crossref","is-referenced-by-count":6,"title":["Selective clinical and immune response of the oligoclonal autoreactive T cells in Omenn patients after cyclosporin A treatment"],"prefix":"10.1093","volume":"167","author":[{"given":"A","family":"Lev","sequence":"first","affiliation":[{"name":"Cancer Research Center"},{"name":"Pediatric Department B North and Immunology Service, Edmond and Lily Safra Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Simon","sequence":"additional","affiliation":[{"name":"Cancer Research Center"},{"name":"Hematology Laboratory, Sheba Medical Center, Tel Hashomer"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Amariglio","sequence":"additional","affiliation":[{"name":"Cancer Research Center"},{"name":"Hematology Laboratory, Sheba Medical Center, Tel Hashomer"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Rechavi","sequence":"additional","affiliation":[{"name":"Cancer Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Somech","sequence":"additional","affiliation":[{"name":"Cancer Research Center"},{"name":"Pediatric Department B North and Immunology Service, Edmond and Lily Safra Children's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,1,11]]},"reference":[{"key":"2021122708460091600_b1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s004310100816","article-title":"Reviewing Omenn syndrome","volume":"160","author":"Aleman","year":"2001","journal-title":"Eur J Pediatr"},{"key":"2021122708460091600_b2","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1182\/blood.V94.10.3468.422k34_3468_3478","article-title":"Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome","volume":"94","author":"Signorini","year":"1999","journal-title":"Blood"},{"key":"2021122708460091600_b3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bmt.2008.11","article-title":"Matched unrelated bone marrow transplant for T+ combined immunodeficiency","volume":"41","author":"Roifman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"2021122708460091600_b4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3476(95)70260-1","article-title":"Treatment of Omenn syndrome by bone marrow transplantation","volume":"127","author":"Gomez","year":"1995","journal-title":"J Pediatr"},{"key":"2021122708460091600_b5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/eji.1830230110","article-title":"T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome)","volume":"23","author":"Schanden\u00e9","year":"1993","journal-title":"Eur J Immunol"},{"key":"2021122708460091600_b6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/adc.87.3.231","article-title":"Treatment with cyclosporine A in a patient with Omenn's syndrome","volume":"87","author":"Meyer- Bahlburg","year":"2002","journal-title":"Arch Dis Child"},{"key":"2021122708460091600_b7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.transproceed.2009.05.001","article-title":"Forty years of publication of transplantation proceedings\u2003\u2013\u2003the second decade: the cyclosporine revolution","volume":"41","author":"Kahan","year":"2009","journal-title":"Transplant Proc"},{"key":"2021122708460091600_b8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.RES.87.9.731","article-title":"Calcineurin and beyond: cardiac hypertrophic signaling","volume":"87","author":"Molkentin","year":"2000","journal-title":"Circ Res"},{"key":"2021122708460091600_b9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaci.2008.02.008","article-title":"Therapeutic approaches for control of transcription factors in allergic disease","volume":"121","author":"Cousins","year":"2008","journal-title":"Allergy Clin Immunol"},{"key":"2021122708460091600_b10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1203\/PDR.0b013e3181c6e554","article-title":"Molecular assessment of thymus capabilities in the evaluation of T-cell immunodeficiency","volume":"67","author":"Amariglio","year":"2010","journal-title":"Pediatr Res"},{"key":"2021122708460091600_b11","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"2021122708460091600_b12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaci.2009.06.048","article-title":"Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells","volume":"124","author":"Somech","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708460091600_b13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2144\/05385MT01","article-title":"Validation of oligonucleotide microarray data using microfluidic low-density arrays: a new statistical method to normalize real-time RT\u2013PCR data","volume":"38","author":"Abruzzo","year":"2005","journal-title":"Biotechniques"},{"key":"2021122708460091600_b14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood.V93.1.242","article-title":"T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly","volume":"93","author":"Edward","year":"1999","journal-title":"Blood"},{"key":"2021122708460091600_b15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08923970701282890","article-title":"Cyclosporin A and tacrolimus (FK506) differentially alter T-cell receptor expression in vivo","volume":"29","author":"Miller","year":"2007","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2021122708460091600_b16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1754.2006.00863.x","article-title":"Omenn syndrome: therapeutic effects of cyclosporin","volume":"42","author":"Rego","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"2021122708460091600_b17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clim.2004.08.016","article-title":"Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection","volume":"115","author":"Dalal","year":"2005","journal-title":"Clin Immunol"},{"key":"2021122708460091600_b18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.143.3.827","article-title":"Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets","volume":"143","author":"Fischer","year":"1989","journal-title":"J Immunol"},{"key":"2021122708460091600_b19","first-page":"638","article-title":"Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease","volume":"15","author":"Xi","year":"2009","journal-title":"Mol Vis"},{"key":"2021122708460091600_b20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/jmg.2005.040329","article-title":"Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene","volume":"43","author":"Lekanne Deprez","year":"2006","journal-title":"J Med Genet"},{"key":"2021122708460091600_b21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0952-7915(03)00104-3","article-title":"Genotype is an important determinant of phenotype in adenosine deaminase deficiency","volume":"15","author":"Hershfield","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"2021122708460091600_b22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood.V97.1.81","article-title":"V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations","volume":"97","author":"Villa","year":"2001","journal-title":"Blood"},{"key":"2021122708460091600_b23","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.transproceed.2005.02.075","article-title":"Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters","volume":"37","author":"Takeuchi","year":"2005","journal-title":"Transplant Proc"},{"key":"2021122708460091600_b24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11010-007-9505-7","article-title":"cDNA microarray analysis of cyclosporin A (CsA)-treated human peripheral blood mononuclear cells reveal modulation of genes associated with apoptosis, cell-cycle regulation and DNA repair","volume":"304","author":"Bai\u00e3o","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"2021122708460091600_b25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.healun.2010.08.001","article-title":"Endothelin-1 antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment","volume":"30","author":"Ramzy","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2021122708460091600_b26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.tp.0000232286.22319.e0","article-title":"Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus","volume":"82","author":"White","year":"2006","journal-title":"Transplantation"},{"key":"2021122708460091600_b27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2009.02930.x","article-title":"RGS4 controls renal blood flow and inhibits cyclosporine-mediated nephrotoxicity","volume":"10","author":"Siedlecki","year":"2010","journal-title":"Am J Transplant"},{"key":"2021122708460091600_b28","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1189\/jlb.0904503","article-title":"Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1","volume":"77","author":"Minguill\u00f3n","year":"2005","journal-title":"J Leukoc Biol"},{"key":"2021122708460091600_b29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.archoralbio.2008.03.008","article-title":"Inhibition of apoptotic signals in overgrowth of human gingival fibroblasts by cyclosporin A treatment","volume":"53","author":"Jung","year":"2008","journal-title":"Arch Oral Biol"},{"key":"2021122708460091600_b30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/00007890-199004000-00028","article-title":"Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells","volume":"49","author":"Metcalfe","year":"1990","journal-title":"Transplantation"},{"key":"2021122708460091600_b31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/09273940600966616","article-title":"Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Beh\u00e7et uveitis","volume":"14","author":"Ahn","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"2021122708460091600_b32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MCP.0b013e3283413105","article-title":"cytokine inhibition in severe asthma: current knowledge and future directions","volume":"17","author":"Corren","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"2021122708460091600_b33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.numecd.2010.02.023","article-title":"Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation","volume":"21","author":"Jublanc","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2021122708460091600_b34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2008.09.037","article-title":"Omenn syndrome: inflammation in leaky severe combined immunodeficiency","volume":"122","author":"Villa","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2021122708460091600_b35","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1111\/j.1442-200X.2010.03135.x","article-title":"Prominent eosinophilia but less eosinophil activation in a patient with Omenn syndrome","volume":"52","author":"Seki","year":"2010","journal-title":"Pediatr Int"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04508.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/167\/2\/338\/41908020\/j.1365-2249.2011.04508.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/167\/2\/338\/41908020\/j.1365-2249.2011.04508.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T20:17:38Z","timestamp":1686428258000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/167\/2\/338\/6422866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,11]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,1,11]]},"published-print":{"date-parts":[[2012,1,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04508.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,2]]},"published":{"date-parts":[[2012,1,11]]}}}